Kim Witczak, a consumer representative on the FDA Psychopharmacologic Advisory Committee, shares her harrowing journey following her husband's tragic death after starting Zoloft. She discusses the hidden risks and side effects of SSRIs, advocating for drug transparency and accountability. Kim highlights the troubling practices of Big Pharma, challenges the 'chemical imbalance' narrative, and emphasizes the need for systemic reform in prescription drug regulation. Her story serves as a wake-up call for anyone using antidepressants and a rallying cry for mental health reform.